Sitagliptin-d6
目录号 : KM33049
CAS No. : 1133211-99-0
Sitagliptin-d6 (MK-0431-d6) 是氘代标记的 Sitagliptin 。Sitagliptin 是一种口服有效的且具有高选择性的 DPP4 抑制剂,其 IC50 值为 19 nM。Sitagliptin 通过竞争性抑制机制 (Kᵢ = 1 nM) 阻断 DPP-4 对胰高血糖素样肽-1 (GLP-1) 和葡萄糖依赖性胰岛素多肽 (GIP) 的降解,从而提升活性肠促胰岛素 (incretin) 水平。Sitagliptin 还可通过激活 cAMP/PKA 和 ERK1/2 通路,直接刺激肠道 L 细胞分泌 GLP-1,该作用独立于 DPP-4。Sitagliptin 在 1 型糖尿病模型中显示出对胰岛移植物的保护作用。Sitagliptin 可用于研究1 型和 2 型糖尿病。
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 生物活性 |
Sitagliptin-d6 (MK-0431-d6) is deuterium labeled Sitagliptin . Sitagliptin is an orally active and highly selective DPP4 inhibitor with an IC50 value of 19 nM. Sitagliptin blocks the degradation of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) by competing inhibition mechanism (Kᵢ = 1 nM), thereby increasing the level of active incretin. Sitagliptin can also directly stimulate the secretion of GLP-1 by intestinal L cells by activating the cAMP/PKA and ERK1/2 pathways, and this effect is independent of DPP-4. Sitagliptin shows protective effects on pancreatic islet grafts in 1-type diabetes models. Sitagliptin can be used for the study of 1-type and 2-type diabetes.
|
| 分子式 |
C16H9D6F6N5O
|
| 分子量 |
413.35
|
| CAS号 |
1133211-99-0
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
| Powder |
-20°C |
3 years |
| |
4°C |
2 years |
| In solvent |
-80°C |
6 months |
| |
-20°C |
1 month |
|